Delisting risk
ENDRA Life Sciences
Developing radio-frequency thermoacoustic ultrasound for point-of-care liver-fat measurement.
$5.11
After-hours close+0.11 (+2.10%)
At close$5.01(−7.49%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions —Insiders 31.76%
Shares outstanding 1.27M · Float —
Float — provider float is below the insider stake.
The provider's float is smaller than the insider stake it should exclude, so it is not shown.
Institutions13F
No 13F holders on record.
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| John Carter Lipman | 9.99% | 115.5K | 13G | Oct 30, 2025 ↗ |
| Anthony DiGiandomenico | 9.90% | 196.7K | 13D | Jun 29, 2026 ↗ |
| ATW Master Fund V LP | 9.90% | 116.0K | 13G | Oct 28, 2025 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Anthony Digiandomenico | director | 136.6K | 10.75% | Jan 23, 2026 |
| Alexander Y. Tokman | director, officer: Chief Executive Officer | 101.9K | 8.03% | Mar 4, 2026 |
| Michael Harsh | director | 65.7K | 5.17% | Jan 23, 2026 |
| Lou Basenese | director | 65.7K | 5.17% | Jan 23, 2026 |
| Richard Jacroux | officer: Chief Financial Officer | 33.5K | 2.63% | Mar 4, 2026 |
1 ten-percent owner holds 9 shares by Form 4, outside the officers-and-directors figure above · 6 people have not refiled in the last 18 months (4.2K shares), so they are not in the figure above
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.